Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2024-05-17

Clinical Trial Update: Adenosine's Effect on STunning Resolution in Acute Myocardial Infarction [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating adenosine's effect on resolution of myocardial stunning after acute myocardial infarction has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Adenosine (Adenosine)

Snippet

Sponsor: Vastra Gotaland Region | Conditions: Myocardial Ischemia | Phase 3 | Status: WITHDRAWN